A nurse is assessing a client who is taking disulfiram and consumed alcohol. Which of the following findings is the priority for the nurse to report to the provider?

Lisinopril is an angiotensin-converting enzyme (ACE) inhibitorthat lowers blood pressure by preventing the synthesis of angiotensin II. A significant secondary effect of ACE inhibition is the reduction of aldosterone secretion, which leads to the retention of potassium by the kidneys. This pharmacological action poses a severe risk of hyperkalemia, necessitating the avoidance of supplemental potassium sources during therapy.

Rationale:

A.Levothyroxine is a synthetic thyroid hormone that does not have a direct pharmacological contraindication with ACE inhibitors like lisinopril. While the nurse should always monitor for general drug interactions, there is no specific mechanism where lisinopril and levothyroxine interfere with each other's safety or efficacy. Patients with both hypertension and hypothyroidism can safely take these medications concurrently.

B.Metformin is a biguanide used for the management of type 2 diabetes and is not contraindicated for use with lisinopril. ACE inhibitors are often the preferred antihypertensive for diabetic patients because they provide renal protection against diabetic nephropathy. The combination is considered clinically beneficial as long as the nurse monitors the patient's renal function and glucose levels regularly.

C.Potassium chloride is contraindicated for concurrent use with lisinopril because both medications contribute to elevated serum potassium levels. ACE inhibitors decrease aldosterone, which normally facilitates potassium excretion; adding a potassium supplement can lead to life-threatening hyperkalemia. This electrolyte imbalance can cause fatal cardiac arrhythmias, making it essential to clarify this prescription with the provider immediately.

D.Acetaminophen is a non-opioid analgesic and antipyretic that is generally safe to use for patients taking lisinopril for hypertension. Unlike non-steroidal anti-inflammatory drugs (NSAIDs), acetaminophen does not typically interfere with the blood pressure-lowering effects of ACE inhibitors or impair renal blood flow. It remains a safe choice for mild pain management in this patient population.

Sumatriptan is a selective serotonin receptor agonist(triptan) that targets 5-HT1B and 5-HT1D receptors to cause cranial vasoconstriction. It effectively inhibits the release of pro-inflammatory neuropeptidesand suppresses pain transmission within the trigeminal vascular system.

Rationale:

A.Reduction in hand tremors is not a therapeutic effect of sumatriptan, which is specific to migraine pathology. Tremors are usually managed with beta-blockers or dopaminergic agents. Sumatriptan does not influence the motor pathways of the central nervous system or the extrapyramidal system to decrease involuntary muscle movements or tremors in patients.

B.Improved skin condition or the reduction of acne breakouts is unrelated to the pharmacological action of sumatriptan. Triptans do not possess antimicrobial or hormonal properties that would affect the sebaceous glands or integumentary system. This statement would indicate a response to dermatological treatments rather than a medication used for acute migraine relief.

C.The statement that migraine headaches are shorter in duration indicates a therapeutic response, as sumatriptan is used for the acute treatment of migraine attacks. By stimulating serotonin receptors, it reverses the vasodilation and perivascular inflammation responsible for the throbbing pain. Success is measured by the rapid relief of pain and associated symptoms like photophobia.

D.Arthritis pain relief is not an effect of sumatriptan because it is not a general analgesic or anti-inflammatory agent like NSAIDs. Sumatriptan specifically targets receptors found in the cranial blood vessels and has no affinity for peripheral joints or musculoskeletal tissues. It would be ineffective in managing chronic joint inflammation or systemic arthritic pain.